{"result": "(\"entity\"<|>MERCAPTOPURINA<|>ORGANIZATION<|>Mercaptopurina is a medication used in the treatment of certain types of cancer and autoimmune diseases.)\n##\n(\"entity\"<|>METFORMINA<|>ORGANIZATION<|>Metformina is a medication primarily used to treat type 2 diabetes.)\n##\n(\"entity\"<|>INDOMETACINA<|>ORGANIZATION<|>Indometacina is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation.)\n##\n(\"entity\"<|>METOTREXATO<|>ORGANIZATION<|>Metotrexato is a chemotherapy agent and immune system suppressant used to treat cancer and autoimmune diseases.)\n##\n(\"entity\"<|>METOPROLOL<|>ORGANIZATION<|>Metoprolol is a beta-blocker used to treat high blood pressure and heart-related conditions.)\n##\n(\"entity\"<|>LISURIDA<|>ORGANIZATION<|>Lisurida is a medication used to treat Parkinson's disease and other conditions.)\n##\n(\"entity\"<|>METRONIDAZOL<|>ORGANIZATION<|>Metronidazol is an antibiotic used to treat various infections.)\n##\n(\"entity\"<|>MORFINA<|>ORGANIZATION<|>Morfina is a powerful opioid pain medication used to treat severe pain.)\n##\n(\"entity\"<|>METAMIZOL<|>ORGANIZATION<|>Metamizol is a pain reliever and antipyretic used in various medical conditions.)\n##\n(\"entity\"<|>NIMODIPINO<|>ORGANIZATION<|>Nimodipino is a calcium channel blocker used to treat certain types of brain injuries.)\n##\n(\"entity\"<|>NIFEDIPINO<|>ORGANIZATION<|>Nifedipino is a medication used to treat high blood pressure and angina.)\n##\n(\"entity\"<|>METILDOPA<|>ORGANIZATION<|>Metildopa is an antihypertensive medication used to treat high blood pressure.)\n##\n(\"entity\"<|>NORFLOXACINO<|>ORGANIZATION<|>Norfloxacino is an antibiotic used to treat bacterial infections.)\n##\n(\"entity\"<|>NITROFURANTOÍNA<|>ORGANIZATION<|>Nitrofurantoína is an antibiotic used primarily to treat urinary tract infections.)\n##\n(\"entity\"<|>METILPREDNISOLONA<|>ORGANIZATION<|>Metilprednisolona is a corticosteroid used to treat inflammation and immune responses.)\n##\n(\"entity\"<|>PARACETAMOL<|>ORGANIZATION<|>Paracetamol is a common pain reliever and fever reducer.)\n##\n(\"entity\"<|>PROPRANOLOL<|>ORGANIZATION<|>Propranolol is a beta-blocker used to treat high blood pressure, anxiety, and other conditions.)\n##\n(\"entity\"<|>NAPROXENO<|>ORGANIZATION<|>Naproxeno is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation.)\n##\n(\"entity\"<|>PIRIZINAMIDA<|>ORGANIZATION<|>Pirizinamida is an antibiotic used in the treatment of tuberculosis.)\n##\n(\"entity\"<|>RANITIDINA<|>ORGANIZATION<|>Ranitidina is a medication used to reduce stomach acid and treat conditions like GERD.)\n##\n(\"entity\"<|>RIFAMPICINA<|>ORGANIZATION<|>Rifampicina is an antibiotic used to treat tuberculosis and other bacterial infections.)\n##\n(\"entity\"<|>RETINOL<|>ORGANIZATION<|>Retinol is a form of vitamin A used in skincare and dietary supplements.)\n##\n(\"entity\"<|>ÁC. PIPEMÍDICO<|>ORGANIZATION<|>Ácido pipemídico is an antibiotic used to treat urinary tract infections.)\n##\n(\"entity\"<|>SULPIRIDA<|>ORGANIZATION<|>Sulpirida is an antipsychotic medication used to treat schizophrenia and other disorders.)\n##\n(\"entity\"<|>TOCOFEROL<|>ORGANIZATION<|>Tocoferol is a form of vitamin E used as a dietary supplement and antioxidant.)\n##\n(\"entity\"<|>PIROXICAM<|>ORGANIZATION<|>Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation.)\n##\n(\"entity\"<|>TAMOXIFENO<|>ORGANIZATION<|>Tamoxifeno is a medication used to treat and prevent breast cancer.)\n##\n(\"entity\"<|>TRIAMTERENO<|>ORGANIZATION<|>Triamtereno is a potassium-sparing diuretic used to treat high blood pressure and fluid retention.)\n##\n(\"entity\"<|>POTASIO<|>ORGANIZATION<|>Potasio is a mineral essential for various bodily functions, including nerve and muscle function.)\n##\n(\"entity\"<|>TEOFILINA<|>ORGANIZATION<|>Teofilina is a medication used to treat respiratory diseases such as asthma and COPD.)\n##\n(\"entity\"<|>VERAPAMILO RETARD<|>ORGANIZATION<|>Verapamilo retard is a long-acting calcium channel blocker used to treat high blood pressure and angina.)\n##\n(\"entity\"<|>PREDNISONA<|>ORGANIZATION<|>Prednisona is a corticosteroid used to treat inflammation and autoimmune conditions.)\n##\n(\"entity\"<|>TETRACICLINA<|>ORGANIZATION<|>Tetraciclina is an antibiotic used to treat a variety of bacterial infections.)\n##\n(\"entity\"<|>PROBENECID<|>ORGANIZATION<|>Probenecid is a medication used to increase uric acid excretion and treat gout.)\n##\n(\"entity\"<|>VERAPAMILO<|>ORGANIZATION<|>Verapamilo is a calcium channel blocker used to treat high blood pressure and heart conditions.)\n##\n(\"entity\"<|>ÁC. VALPROICO<|>ORGANIZATION<|>Ácido valproico is a medication used to treat epilepsy and bipolar disorder.)\n##\n(\"entity\"<|>ZIDOVIDINA<|>ORGANIZATION<|>Zidovudina is an antiretroviral medication used to treat HIV/AIDS.)\n##\n(\"relationship\"<|>METOTREXATO<|>METILDOPA<|>Both Metotrexato and Metildopa are medications that can affect nutrient absorption and metabolism<|>4)\n##\n(\"relationship\"<|>TAMOXIFENO<|>METOTREXATO<|>Tamoxifeno and Metotrexato can interact with nutrient metabolism, particularly affecting vitamin levels<|>4)\n##\n(\"relationship\"<|>MORFINA<|>PARACETAMOL<|>Morfina and Paracetamol are both used for pain relief but differ in their strength and application<|>5)\n##\n(\"relationship\"<|>NIMODIPINO<|>NIFEDIPINO<|>Nimodipino and Nifedipino are both calcium channel blockers used to treat cardiovascular conditions<|>6)\n##\n(\"relationship\"<|>RANITIDINA<|>PARACETAMOL<|>Ranitidina can affect the absorption of Paracetamol due to its impact on stomach acidity<|>3)\n##\n(\"relationship\"<|>ZIDOVIDINA<|>METOTREXATO<|>Zidovudina and Metotrexato can both influence the metabolism of certain vitamins<|>3)\n##\n(\"relationship\"<|>VERAPAMILO<|>VERAPAMILO RETARD<|>Verapamilo and Verapamilo retard are both used to treat high blood pressure but differ in their release mechanisms<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ortisona | | |\n| Mercaptopurina | Metformina | Indometacina | | |\n| Metotrexato | Metoprolol | Lisurida | | |\n| Metronidazol | Morfina | Metamizol | | |\n| Nimodipino | Nifedipino retard | Metildopa | | |\n| Norfloxacino | Nitrofurantoína | Metilprednisolona | | |\n| Paracetamol | Propranolol | Naproxeno | | |\n| Pirizinamida | Ranitidina | Nifedipino | | |\n| Rifampicina | Retinol | Ác. pipemídico | | |\n| Sulpirida | Tocoferol | Piroxicam | | |\n| Tamoxifeno | Triamtereno | Potasio | | |\n| Teofilina | Verapamilo retard | Prednisona | | |\n| Tetraciclina | | Probenecid | | |\n| Verapamilo | | Ác. valproico | | |\n| Zidovudina | | | | |\n\nModificado de Tuneu7.\n---\nTema 44. Interacción entre dieta y fármacos 711\n\ncionan con retraso del vaciamiento gástrico o «efecto masa» que induce saciedad, estomatitis u otros efectos secundarios gastrointestinales (náuseas, vómitos).\n\n### 3.2.2. Efecto sobre la absorción de nutrientes\n\nLos medicamentos pueden también disminuir la absorción de los nutrientes; bien por un efecto directo en la luz intestinal o efectos sobre la mucosa. En el primer caso, el fármaco puede causar formación de precipitados insolubles, reducción en el tiempo de tránsito intestinal (por ejemplo, los laxantes pueden ocasionar esteatorrea y pérdidas de calcio y potasio13) o modificación del pH gástrico (antiácidos, anti-H2, inhibidores de la bomba de protones) que disminuyen la absorción de la vitamina B12, tiamina y del hierro6. En el segundo, puede actuar impidiendo la normal función absortiva de la mucosa gastrointestinal (por ejemplo, por un efecto tóxico directo de colchicina o neomicina sobre la mucosa intestinal. La malabsorción producida por el efecto de un fármaco también puede ser secundaria: el fármaco modifica la absorción, disponibilidad o metabolismo de un nutriente lo que, a su vez, provoca malabsorción y deficiencia de otro nutriente. Es lo que ocurre, por ejemplo, cuando un tratamiento con fenitoína estimula el catabolismo de la vitamina D, produciendo una deficiencia funcional, que a su vez dificultará la absorción de calcio.\n\n### 3.2.3. Efecto sobre el metabolismo de los nutrientes\n\nLos fármacos pueden alterar el metabolismo de los nutrientes –especialmente vitaminas– mediante la inducción de los sistemas enzimáticos responsables de su degradación. Las vitaminas D, B6 y B12 y el ácido fólico pueden sufrir procesos de este tipo. La isoniazida, la levodopa y los anticonceptivos orales presentan interacciones complejas que afectan al metabolismo de la vitamina B6. Otros fármacos se conocen como antivitaminas por su competencia con las vitaminas. Por ejemplo, metotrexato se une a la dihidrofolato reductasa provocando un déficit de folatos y los anticoagulantes actúan como factores antivitamina K13. La soja interacciona con fármacos como el tamoxifeno o el toremifeno, por contener fitoestrógenos, principalmente ipriflavona que actúa como inhibidor de enzimas CYP1A2 y CYP2C9.\n\n### 3.2.4. Efecto sobre la excreción de nutrientes\n\nLos fármacos pueden modificar la excreción de nutrientes, aumentando o disminuyendo sus niveles, especialmente de los minerales. Como ejemplo, los diuréticos de asa provocan la pérdida de sodio, potasio, magnesio, calcio y tiamina2, mientras que las tiazidas retienen calcio. Este aumento en la excreción puede deberse en otros casos a que el fármaco ocasione un desplazamiento del nutriente en su unión a proteínas plasmáticas.\n\n### 3.3. Implicación del estado nutricional en la acción de los fármacos\n\nEl estado nutricional del individuo puede afectar a la actividad de los fármacos. Como ejemplo, podemos señalar que la hipoalbuminemia supone una menor cantidad del fármaco unido a albúmina y, por tanto, un mayor porcentaje de medicamento libre en el plasma, con lo que pueden aparecer signos de toxicidad a dosis terapéuticas, como ocurre con la difenilhidantoína o los cumarínicos. También en la desnutrición se producen\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}